Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
116
Frequently Asked Questions
What is Market Cap of Silence Therapeutics Plc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Silence Therapeutics Plc - ADR market cap is $268.76M.
What is the 52-week high for Silence Therapeutics Plc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Silence Therapeutics Plc - ADR 52 week high is $20.48 as of September 09, 2025.
What is the 52-week low for Silence Therapeutics Plc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Silence Therapeutics Plc - ADR 52 week low is $1.97 as of September 09, 2025.
What is Silence Therapeutics Plc - ADR stock price today?
Silence Therapeutics Plc - ADR stock price today is $5.38.
What was Silence Therapeutics Plc - ADR stock price yesterday?
Silence Therapeutics Plc - ADR stock price yesterday was $5.69.
What is the PE ratio of Silence Therapeutics Plc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Silence Therapeutics Plc - ADR’s P/E ratio is -3.40.
What is the Price-to-Book ratio of Silence Therapeutics Plc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Silence Therapeutics Plc - ADR P/B ratio is 2.8544.
What is the 50-day moving average of Silence Therapeutics Plc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Silence Therapeutics Plc - ADR 50-day moving average is $5.73.
How many employess does Silence Therapeutics Plc - ADR has?